Sage Works Towards Improvement in Lives Of Parkinson's Patients with their mPower App
SEATTLE,WA: Recently it has been reported that a new iphone app called mPower has been developed by Sage with support from the Robert Wood Johnson Foundation to track Parkinson disease symptoms in real-time and share the information monitored from the app with researchers. A Dataset that captures everyday experiences of approximately 9500 people has been collected by Sage Bionetworks with the aim to accelerate scientific progress toward treatments for people with Parkinson’s disease.
Researchers are provided with extraordinary observations pertaining to daily changes in symptoms and effects of medication for people with Parkinson’s from datasets collected consistently through the mPower app.
According to reports, it is evident that seven to ten million people worldwide are living with Parkinson’s disease, a degenerative disorder which causes tremors, speech problems, and interfere with memory. The data collected by mPower app highlights the capacities of an individual affected by the disease, mainly dexterity, balance and gait, memory, and certain vocal characteristics, through tasks that make use of iPhone sensors. Dexterity is measured post completion of a speed tapping exercise preformed on the iphone touchscreen by participants and speech evaluation is carried out when participants are asked to record themselves pronouncing vowels for 10 seconds using the iphone’s microphone. Effects of medicines on the symptoms of the disease is tracked when activities of participants or patients is monitored along with their medication. A complete survey is also conducted when it comes to rating the severity of the symptoms.
Doctors and scientists are quickly able to retrieve data on an ongoing process using iphone apps for medical research with the aid of mPower. Participants using mPower have the option to choose with whom they want to share their data with. Enormous variation of symptoms could help researcher’s better pinpoint windows of interference from preliminary analysis of data from Sage. Distinct patterns between medication intake and symptoms could inform care and treatment regimes in the long run. With the opening of data to all researchers, Sage hopes to accelerate its insights for implementation in clinics and thus help towards the improvement in the lives of people with Parkinson’s disease.
By Debra Jensen, CIO, Charlotte Russe
By Phil Jordan, CIO, Telefonica
By Alberto Ruocco, CIO, American Electric Power
By Sven Gerjets, SVP-IT, DIRECTV
By Adrian Mebane, VP-Global Ethics & Compliance, The Hershey...
By Mike Fitton, Wireless Business Unit Director, Altera
By Jim Kaskade, VP and GM, Big Data & Analytics, CSC
By Graham Welch, Director-Cisco Security, Cisco
By Michael Watkins, Senior Product Director, Global Knowledge
By Nelson C. Vincent, EdD, VP for IT and CIO, University of...
By Sharon Gietl, VP-IT & CIO, The Doe Run Company
By Arnold Leap, CIO, 1-800-Flowers.com
By Gary Barlet, CIO, USPS OIG
By Mike Dieter, CTO, Transplace
By Bill Schimikowski, VP, Customer Experience, Fidelity...
By Kevin Kometer, CIO, CME Group
By John Landwehr, Public Sector CTO, Adobe
By Marc Probst, CIO & VP, Intermountain Healthcare
By Charles Koontz, President & CEO, GE Healthcare IT & Chief...
By Jeff Bauserman, VP-Information Systems & Technology,...